Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date February 28, 2020 · Filed March 03, 2020
Section 16 reporting ended · disclosed 2020-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 122,075 |
Ending reported balance
After 2020-02-28 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-02-28 · Exercise / conversion · Acquired 27,422 · Balance 140,744 F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Row 2 · 2020-02-28 · Tax withholding · Disposed 4,503 · Balance 136,241 F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Row 3 · 2020-02-28 · Tax withholding · Disposed 14,166 · Balance 122,075 F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $27.37 · Expires 2020-02-28 | Direct | 0 |
Reported balance
After 2020-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-28 · Exercise / conversion · Disposed 27,422 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 2,686 |
Reported balance
Holding disclosure · report date 2020-02-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,686 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2020 Filed Mar 3, 2020 17:49 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 27,422 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-20-004019 · doc4.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,422 shares Expires 2020-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:49 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 14,166 | $36.45 | $516,350.70 |
DisclosureSEC source: 0001225208-20-004019 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,075 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:49 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,503 | $33.42 | $150,490.26 |
DisclosureSEC source: 0001225208-20-004019 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,241 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:49 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 27,422 | $27.37 | $750,540.14 |
DisclosureSEC source: 0001225208-20-004019 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 24,155 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · derivative · entry 7 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,155 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 18,438 | $36.80 | $678,518.40 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · nonDerivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,322 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,943 | $34.72 | $67,460.96 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,760 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,290 | $34.72 | $44,788.80 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,703 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 3,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,993 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:15 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 24,155 | $34.59 | $835,521.45 |
DisclosureSEC source: 0001225208-20-003782 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2020 Filed Feb 25, 2020 23:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,574 | $35.72 | $56,223.28 |
DisclosureSEC source: 0001225208-20-003503 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,041 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F2 · price: Price is the closing price of Pfizer common stock on February 21, 2020. Read SEC document |
| November 27, 2019 Filed Dec 3, 2019 20:39 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015164 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,435 Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 15,211 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · derivative · entry 10 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,211 Underlying: Common Stock · 15,211 shares Expires 2026-02-28 F9 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F9 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 18,050 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · derivative · entry 9 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,050 Underlying: Common Stock · 18,050 shares Expires 2024-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 3,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,607 F7 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 25,729 | $0.00 Strike: $32.23 | $0.00 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · derivative · entry 8 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,729 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 15,890 | $42.31 | $672,305.90 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,125 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,819 | $42.93 | $206,879.67 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,015 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,926 | $42.93 | $168,543.18 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,834 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 8,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,760 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:29 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 25,729 | $32.23 | $829,245.67 |
DisclosureSEC source: 0001225208-19-004207 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 00:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,759 | $43.08 | $75,777.72 |
DisclosureSEC source: 0001225208-19-003773 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,014 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:10 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 30,864 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-19-003773 · doc4.xml · derivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,864 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,610 | $41.91 | $402,755.10 |
DisclosureSEC source: 0001225208-19-003773 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,773 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,756 | $42.96 | $333,197.76 |
DisclosureSEC source: 0001225208-19-003773 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,383 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 22, 2019 Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:10 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 30,864 | $21.03 | $649,069.92 |
DisclosureSEC source: 0001225208-19-003773 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:36 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 18,514 | $40.16 | $743,522.24 |
DisclosureSEC source: 0001225208-18-012255 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,846 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:36 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 8,300 | $40.17 | $333,411.00 |
DisclosureSEC source: 0001225208-18-012255 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,360 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 33,040 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,040 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 20,055 | $35.70 | $715,963.50 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,433 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,359 | $36.31 | $230,895.29 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,488 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 33,040 | $27.37 | $904,304.80 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,538 | $37.09 | $57,044.42 |
DisclosureSEC source: 0001225208-18-004454 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,661 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:01 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,028 | $37.09 | $112,308.52 |
DisclosureSEC source: 0001225208-18-004657 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,807 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:01 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 7,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004657 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,373 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 28,288 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-18-004454 · doc4.xml · derivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,288 shares Expires 2018-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,026 | $35.98 | $324,755.48 |
DisclosureSEC source: 0001225208-18-004454 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,199 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,544 | $36.26 | $237,285.44 |
DisclosureSEC source: 0001225208-18-004454 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,225 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 23, 2018 Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 28,288 | $18.90 | $534,643.20 |
DisclosureSEC source: 0001225208-18-004454 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:43 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 18,119 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003963 · doc4.xml · derivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,119 Underlying: Common Stock · 18,119 shares Expires 2025-02-22 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:43 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 21,673 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003963 · doc4.xml · derivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,673 Underlying: Common Stock · 21,673 shares Expires 2023-02-22 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:43 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 4,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003963 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,481 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 22:11 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018520 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,136 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,907 | $34.28 | $65,371.96 |
DisclosureSEC source: 0001225208-17-005100 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,895 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,805 | $34.28 | $61,875.40 |
DisclosureSEC source: 0001225208-17-005100 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,802 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 5,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005100 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,607 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:10 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 20,216 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004769 · doc4.xml · derivative · entry 8 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,216 Underlying: Common Stock · 20,216 shares Expires 2024-02-23 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:10 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 24,351 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004769 · doc4.xml · derivative · entry 7 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,351 Underlying: Common Stock · 24,351 shares Expires 2022-02-23 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:10 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 36,408 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-17-004769 · doc4.xml · derivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,408 shares Expires 2017-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 17,627 | $32.49 | $572,701.23 |
DisclosureSEC source: 0001225208-17-004769 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,450 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.